Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Therapix Biosciences Ltd (TRPX)

Therapix Biosciences Ltd (TRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,775
  • Shares Outstanding, K 3,510
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,520 K
  • 60-Month Beta 0.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 118.97

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +23.57%
on 10/10/19
3.24 -21.12%
on 09/23/19
-0.44 (-14.74%)
since 09/20/19
3-Month
2.04 +25.38%
on 08/12/19
4.69 -45.46%
on 07/23/19
+0.26 (+11.21%)
since 07/22/19
52-Week
2.04 +25.38%
on 08/12/19
9.30 -72.50%
on 11/05/18
-1.86 (-42.13%)
since 10/22/18

Most Recent Stories

More News
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210

Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Provides Update on Planned Merger With Destiny Biosciences Global Corp.

Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today an...

TRPX : 2.54 (+1.60%)
Nasdaq Grants Therapix Biosciences Extension to Comply With Stockholders' Equity Requirement

Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide(TM)), a Non-Opiate Based Pain Management Supplement

TEL AVIV, Israel, July 31 2019 /PRNewswire Therapix Biosciences Ltd. ("Therapix" or the "Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based...

TRPX : 2.54 (+1.60%)
RESPIRERX PHARMACEUTICALS INC. SEND NOTICE LETTER TO THE BOARD OF DIRECTORS OF THERAPIX BIOSCIENCES LTD.

RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the research and development of cannabinoids for the treatment of sleep-related breathing disorders, announces that...

TRPX : 2.54 (+1.60%)
RSPI : 0.3100 (-30.65%)
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 Million

Therapix Biosciences Ltd. ("Therapix" or "the Company") (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today the...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data

Therapix Biosciences Ltd. ("Therapix" or "the Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today condensed...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Issues Shareholder Update Letter

Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today released a...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance

Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that...

TRPX : 2.54 (+1.60%)
Therapix Biosciences Announces Pricing of $2.25 Million Registered Direct Offering

Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced that...

TRPX : 2.54 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade TRPX with:

Business Summary

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to...

See More

Key Turning Points

2nd Resistance Point 2.86
1st Resistance Point 2.68
Last Price 2.54
1st Support Level 2.38
2nd Support Level 2.27

See More

52-Week High 9.30
Fibonacci 61.8% 6.53
Fibonacci 50% 5.67
Fibonacci 38.2% 4.81
Last Price 2.54
52-Week Low 2.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar